期刊文献+

核受体辅助抑制因子中ETO结合结构域的确定

Determination of ETO interaction domain within nuclear receptor co-repressor
原文传递
导出
摘要 目的 为消除急性髓系白血病标志基因AML1/ETO的活性 ,确定核受体辅助抑制因子(nuclearreceptorco repressor,N CoR)与ETO基因相互作用的活性部位。方法 用PCR扩增不同区段的N CoR(N CoRY) ,克隆入酵母表达质粒pGADGL中 ,构建获得pGADGL/N CoRY。应用酵母双杂交技术及X gal染色确定pGADGL/N CoRY 10个区段的N CoR是否与ETO结合。结果 N CoR的 988~ 112 6氨基酸残基与 15 5 1~ 180 1氨基酸残基共存时 ,才能与ETO发生结合作用 ,是与ETO相互作用的结构域。结论 N CoR两个结构域能与ETO的两个锌指结构作用 ,保持两种蛋白之间的稳定结合。 Objective To determine the ETO interaction domain of nuclear receptor co repressor (N CoR) for abolishing the biological function of AML1 ETO. Methods Ten different regions of N CoR (N CoRYs) were generated by means of polymerase chain reaction (PCR), and cloned into yeast expression plasmid pGADGL to construct pGADGL/N CoRYs. The yeast two hybrid technique and X gal staining were used to determine the binding between the 10 different regions of N CoR and ETO. Results It was shown that the co existance of 988~1?126 and 1?551~1?803 amino acid residues of N CoRY was the ETO interaction domains required for the binding with ETO. Conclusion Two domains of N CoR that interact with two zinc fingers of ETO, and keep stable binding between the two proteins were identified.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2002年第12期621-623,共3页 Chinese Journal of Hematology
基金 国家自然科学基金资助项目 (3 9970 3 17) 国家杰出青年基金资助项目 (3 0 0 2 5 0 19) 天津市自然科学基金资助项目(0 0 3 80 3 2 11) 教育部骨干教师基金资助项目
关键词 髓系白血病 核受体辅助抑制因子 ETO基因 Leukemia, myeloid Nuclear receptor co repressor Gene, ETO
  • 相关文献

参考文献7

  • 1Kitabayashi I, Yakoyama A, Shimizu K, et al. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J, 1998, 17:2994-3004.
  • 2Wang J, Wang M, Liu JM. Transformation properties of the ETO gene, fusion partner in t(8;21) leukemias. Cancer Res, 1997, 57:2951-2955.
  • 3Yergeau DA, Hetherington CJ, Wang Q, et al. Embryonic lethality and impairment of hematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nat Genet, 1997, 15:303-306.
  • 4Wang J, Hoshino T, Redner RL, et al. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc Natl Acad Sci U S A, 1998, 95:10860-10865.
  • 5Hassig CA, Fleischer TC, Billin AN, et al. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell, 1997, 89:341-347.
  • 6Laherty CD, Yang WM, Sun JM, et al. Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell, 1997, 89:349-356.
  • 7Wang J, Sautararajuh Y, Redner RL, et al. Inhibitors of histone deacetylase relieve ETO mediated repression and induce differentiation of AML1-ETO leukemia cells. Cancer Res, 1999, 59:2766-2769.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部